Sun Pharma ready for another US buyout
Dilip Sanghvi, the CMD of Sun Pharmaceuticals, is ready to make his next acquisition, after Taro management, in the US market. He is also eager to bag opportunities back home in India. Sanghvi said, "We are looking at specialty therapy area in India. For now, our focus for acquisitions is more on the US market."
